Melis Erçelik

Melis Erçelik

Auto-generated profile, based on publicly available information

Melis Erçelik

Bursa Uludag University

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 May 2023 in Turkish Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
MEMelis Erçeli̇k
Melis Erçeli̇k
BTBerrin Tunca
Berrin Tunca
SASecil AK-AKSOY
Secil AK-AKSOY
ÇAÇağla Ak Aksoy
Çağla Ak Aksoy
Gulcin TezcanGulcin Tezcan
Gulcin Tezcan
Objectives: The purpose of this study was to investigate the effect of Olea europaea L. leaf extract (OLE) on senescence and senescence-associated secretory phenotype (SASP) caused by temozolomide (TMZ) in glioblastoma (GB).Materials and Methods: A senescence beta-galactosidase assay and a colony formation assay were used to determine the effects of OLE, TMZ, and OLE + TMZ on the cellular senescence and aggressiveness of GB cell lines T98G and U87MG. mRNA expression levels of p53, a senescence factor, interleukin (IL)-6, matrix metalloproteinases (MMP)-9, and nuclear factor kappa B1 (NF-kappa B1) as SASP factors and Bcl-2 and Bax as senolytic markers were assessed using quantitative reverse transcription-real-time polymerase chain reaction. Cells were double-stained with acridine orange and propidium iodide to observe the cell morphology.Results: TMZ increased the senescence rate of GB cells (p<0.001). Besides, OLE + TMZ reduced the proportion of senescent cells (p<0.001) and their capability to form colonies compared to TMZ-only-treated cells. Additionally, OLE + TMZ co-treatment elevated the mRNA expression levels of MMP-9, IL-6, NF-kappa B1, p53, and the Bax/Bcl-2 ratio compared to TMZ-only treatment. Especially in U87MG cells, involvement of OLE in TMZ treatments increased more than six times in the Bax/Bcl-2 ratio compared to TMZ-only, which induced the apoptosis-like morphological features (p<0.0001).Conclusion: Collectively, our findings presented the inhibitory effect of OLE on TMZ-mediated SASP-factor production in GB and, accordingly, its potential contribution to elongate the time of recurrence.

30 January 2026 in Turkish Journal of Pharmaceutical Sciences
Verified
Journal Article
Open access
PDF file
SFSena Ferah
Sena Ferah
MÇMine Çamlibel
Mine Çamlibel
MEMelis Erçeli̇k
Melis Erçeli̇k
ÇTÇağla Teki̇n
Çağla Teki̇n
Gulcin TezcanGulcin Tezcan
Gulcin Tezcan
BTBerrin Tunca
Berrin Tunca
Overcoming Intrinsic and Acquired Temozolomide Resistance in Glioblastoma: Fisetin as a Potential Strategy to Enhance Sensitivity via ZEB1 Modulation - Turkish Journal of Pharmaceutical Sciences

20 June 2023 in Turkish Journal of Colorectal Disease
Verified
Journal Article
Closed access
SASecil AK-AKSOY
Secil AK-AKSOY
TYTuncay Yılmazlar
Tuncay Yılmazlar
MEMelis Erçelik
Melis Erçelik
ÇTÇağla Tekin
Çağla Tekin
NUNesrin Uğraş
Nesrin Uğraş
Ozgen IsikOzgen Isik
Ozgen Isik

31 March 2026 in Journal of Neuro-Oncology
Verified
Journal Article
Open access
MGMelisa Gurbuz
Melisa Gurbuz
CTCagla Tekin
Cagla Tekin
MEMelis Ercelik
Melis Ercelik
SKSevin Avsar Koc
Sevin Avsar Koc
FKFeray Tura Köçkar
Feray Tura Köçkar
BTBerrin Tunca
Berrin Tunca
Background: Atypical teratoid/rhabdoid tumors (AT/RT) are aggressive pediatric CNS malignancies characterized by SMARCB1 loss, which leads to the dysregulated expression of Enhancer of Zeste Homolog 2 (EZH2), a key catalytic component of the Polycomb Repressive Complex 2 (PRC2). This dysregulation results in aberrant trimethylation of histone H3 at lysine 27 (H3K27me3), driving tumor progression. While EZH2 inhibitors like tazemetostat are in clinical use, their efficacy remains limited, necessitating a deeper understanding of PRC2 regulation. We investigated the role of long non-coding RNAs (lncRNAs) in modulating the EZH2-PRC2 axis in AT/RT. Methods: Expression levels of lncRNAs (MALAT1, ANRIL, KCNQ1OT1) were analyzed via RT-PCR in 10 archival AT/RT patient tissues. RNA immunoprecipitation (RIP) was performed to identify direct interactions with EZH2. The functional impact of MALAT1 inhibition on H3K27me3 levels, mesenchymal markers (CDH2, TWIST, ZEB1), and tumorigenic behaviors (migration, invasion, sphere formation) was evaluated in vitro. Results: MALAT1, ANRIL, and KCNQ1OT1 were significantly overexpressed in AT/RT tissues ( p < 0.05). RIP assays revealed that only MALAT1 directly interacts with EZH2 in DAOY and primary AT/RT cells. MALAT1 knockdown significantly reduced H3K27me3 levels ( p < 0.05) and markedly impaired cell migration, invasion, and sphere-forming capacity. These phenotypic changes were associated with the downregulation of key mesenchymal markers (CDH2, TWIST, ZEB1). Conclusions: Our findings identify MALAT1 as a critical epigenetic regulator in AT/RT that interacts with EZH2 to maintain the PRC2-mediated repressive landscape. Targeting the MALAT1-EZH2 axis provides a novel translational perspective to enhance the efficacy of epigenetic therapies in AT/RT.

21 June 2026 in Online Türk Sağlık Bilimleri Dergisi
Verified
Journal Article
Open access
MEMelis Erçelik
Melis Erçelik
ÇTÇağla Tekin
Çağla Tekin
PEPınar Eser
Pınar Eser
ABAhmet Bekar
Ahmet Bekar
HKHasan Kocaeli
Hasan Kocaeli
BTBerrin Tunca
Berrin Tunca
Glioblastoma (GB) is an aggressive brain tumor characterized by extensive heterogeneity. We aimed to generate patient-derived GB organoids preserving histological features and to establish a biobank for future studies. Materials and Methods: Tumor tissues from GB patients were dissected into 0.5–1 mm fragments and cultured for 14 days in organoid medium under orbital shaking. Immunohistochemical analysis was performed to assess GFAP, OLIG2, IDH-1, p53, ATRX, and Ki67 expression before and after organoid formation. Results: All tumor samples formed spherical organoids within 14 days. Histological analysis showed preservation of GB-specific morphological features, including nuclear atypia and pleomorphism. GFAP, OLIG2, and ATRX expression patterns were concordant between parental tumors and organoids in cases. IDH-1 expression was consistent in three patients. Ki67 and p53 expression levels showed similar patterns between organoids and corresponding tumors. Conclusion: Patient-derived GB organoids retain key histopathological features and may serve as a platform for GB modeling.

12 December 2022 in Sakarya Medical Journal
Verified
Journal Article
Open access
AKAhmet Karamustafaoğlu
Ahmet Karamustafaoğlu
SASecil Ak Aksoy
Secil Ak Aksoy
BTBerrin Tunca
Berrin Tunca
MEMelis Erçeli̇k
Melis Erçeli̇k
ÇTÇağla Teki̇n
Çağla Teki̇n
EKEkrem Kaya
Ekrem Kaya
Introduction: Metastasectomy is one of the effective treatment methods for liver metastases developing from primary colorectal cancer (CRC). However, recurrence after metastasectomy is the biggest problem in these cancers. The present study aimed to examine the role of Epithelial-Mesenchymal Transition (EMT) in the development of recurrence after metastasectomy in liver metastases from primary CRCs. Materials and Methods: In the study, 85 patients were evaluated. RNA was isolated from archive tumors and normal tissues of the patients. Expression profiles of 7 different EMT markers were examined using qRT-PCR. Results: Metastasis to the liver developed in 24.7% (n=21) of 85 CRC. Recurrence was observed in 42.3% (n=9) of liver metastases after metastasectomy. Statistically significant increases were detected in the expression of EMT markers TWIST and SNAIL in the development of mCC in primary CRC (p